{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:32:09Z","timestamp":1790400729346,"version":"4.1.0"},"reference-count":44,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1254\/jphs.14r03cr","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T11:25:08Z","timestamp":1409829908000},"page":"14-20","source":"Crossref","is-referenced-by-count":15,"title":["The Cardiovascular Actions of DOPA Mediated by the Gene Product of ocular albinism 1"],"prefix":"10.1254","volume":"126","author":[{"given":"Yoshio","family":"Goshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Masukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motokazu","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bartholini G, Burkard WP, Pletscher A. Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature. 1967;215:852\u2013853.","DOI":"10.1038\/215852b0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ng KY, Chase TN, Colburn RW, Kopin IJ. L-Dopa-induced release of cerebral monoamines. Science. 1970;170:76\u201377.","DOI":"10.1126\/science.170.3953.76"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Lloyd KG, Davidson L, Hornykiewicz O. The neurochemistry of Parkinson\u2019s disease: effect of L-dopa therapy. J Pharmacol Exp Ther. 1975;195:453\u2013464.","DOI":"10.1016\/S0022-3565(25)30363-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Misu Y, Goshima Y, Ueda H, Okamura H. Neurobiology of L-DOPAergic systems. Prog Neurobiol. 1996;49:415\u2013454.","DOI":"10.1016\/0301-0082(96)00025-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Misu Y, Goshima Y. Is L-dopa an endogenous neurotransmitter? Trends Pharmacol Sci. 1993;14:119\u2013123.","DOI":"10.1016\/0165-6147(93)90082-U"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Nakamura S, Goshima Y, Yue JL, Miyamae T, Misu Y. Transmitter-like 3,4-dihydroxyphenylalanine is tonically released by nicotine in striata of conscious rats. Eur J Pharmacol. 1992;222:75\u201380.","DOI":"10.1016\/0014-2999(92)90465-G"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Yue JL, Okamura H, Goshima Y, Nakamura S, Geffard M, Misu Y. Baroreceptor-aortic nerve-mediated release of endogenous L-3,4- dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats. Neuroscience. 1994;62:145\u2013161.","DOI":"10.1016\/0306-4522(94)90321-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Komori K, Uesaka S, Yamaoka H, Fujita K, Yamaoka K, Naitoh H, et al. Identification of L-dopa immunoreactivity in some neurons in the human mesencephalic region: a novel dopa neuron group? Neurosci Lett. 1993;157:13\u201316.","DOI":"10.1016\/0304-3940(93)90631-T"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Okamura H, Kitahama K, Mons N, Ibata Y, Jouvet M, Geggard M. L-dopa-immunoreactive neurons in the rat hypothalamic tuberal region. Neurosci Lett. 1988;95:42\u201346.","DOI":"10.1016\/0304-3940(88)90629-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Sugaya Y, Sasaki Y, Goshima Y, Kitahama K, Kusakabe T, Miyamae T, Kato T, Misu Y. Autoradiographic studies using L-[(14)C]DOPA and L-DOPA reveal regional Na(+)-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS. Neuroscience. 2001;104:1\u201314.","DOI":"10.1016\/S0306-4522(01)00008-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Goshima Y, Kubo T, Misu Y. Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices. Br J Pharmacol. 1986;89:229\u2013234.","DOI":"10.1111\/j.1476-5381.1986.tb11139.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kubo T, Yue JL, Goshima Y, Nakamura S, Misu Y. Evidence for L-dopa systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Neurosci lett. 1992;140:153\u2013156.","DOI":"10.1016\/0304-3940(92)90090-T"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Akbar M, Ishihara K, Sasa M, Misu Y. Inhibition by L-3,4-dihydroxyphenylalanine of hippocampal CA1 neurons with facilitation of noradrenaline and gamma-aminobutyric acid release. Eur J Pharmacol. 2001;414:197\u2013203.","DOI":"10.1016\/S0014-2999(01)00793-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Furukawa N, Goshima Y, Miyamae T, Sugiyama Y, Shimizu M, Ohshima E, et al. L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compounds. Jpn J Pharmacol. 2000;82:40\u201347.","DOI":"10.1254\/jjp.82.40"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al; Cgtp Collaborators. The Concise Guide to PHARMACOLOGY 2013\/14: G protein-coupled receptors. Br J Pharmacol. 2013;170:1459\u20131581.","DOI":"10.1111\/bph.12445"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS. L-DOPA is an endogenous ligand for OA1. PLoS Biology. 2008;6:e236.","DOI":"10.1371\/journal.pbio.0060236"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Schiaffino MV, d\u2019Addio M, Alloni A, Baschirotto C, Valetti C, Cortese K, et al. Ocular albinism: evidence for a defect in an intracellular signal transduction system. Nat Genet. 1999;23:108\u2013112.","DOI":"10.1038\/12715"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Garner A, Jay BS. Macromelanosomes in X-linked ocular albinism. Histopathology. 1980;4:243\u2013254.","DOI":"10.1111\/j.1365-2559.1980.tb02919.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 O\u2019Donnell FE, Hambrick GW Jr, Green WR Jr, Iliff WJ, Stone DL. X-linked ocular albinism. An oculocutaneous macromelanosomal disorder. Arch Ophthalmol. 1976;94:1883\u20131892.","DOI":"10.1001\/archopht.1976.03910040593001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Jaeger CB, Ruggiero DA, Albert VR, Park DH, Joh TH, Reis DJ. Aromatic L-amino acid decarboxylase in the rat brain: immunocytochemical localization in neurons of the brain stem. Neuroscience. 1984;11:691\u2013713.","DOI":"10.1016\/0306-4522(84)90053-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Hiroshima Y, Miyamoto H, Nakamura F, Masukawa D, Yamamoto T, Muraoka H, et al. Ocular albinism 1 (OA1), a G-protein coupled receptor GPR143, is a receptor that mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii. Br J Pharmacol. 2014;171:403\u2013414.","DOI":"10.1111\/bph.12459"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Goldstein M, Fuxe K, Hokfelt T. Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol Rev. 1972;24:293\u2013309.","DOI":"10.1016\/S0031-6997(25)06917-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Bugiardini R, Morgagni G, Pozzati A, Ottani F, Borghi A, Lenzi S, et al. Effect of oral levodopa and carbidopa on coronary spasm in variant angina pectoris. Am J Cardiol. 1987;60:489\u2013493.","DOI":"10.1016\/0002-9149(87)90291-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Judy WV, Watanabe AM, Henry DP, Besch HR Jr, Aprison B. Effect of l-dopa on sympathetic nerve activity and blood pressure in the spontaneously hypertensive rat. Circ Res. 1978;43:24\u201328.","DOI":"10.1161\/01.RES.43.1.24"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Whitsett TL, Halushka PV, Goldberg LI. Attenuation of postganglionic sympathetic nerve activity by L-dopa. Circ Res. 1970;27:561\u2013570.","DOI":"10.1161\/01.RES.27.4.561"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Kohli JD. Peripheral dopamine receptors. Am J Hypertens. 1990;3:25S\u201328S.","DOI":"10.1093\/ajh\/3.6.25S"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Felder RA, Felder CC, Eisner GM, Jose PA. The dopamine receptor in adult and maturing kidney. Am J Physiol. 1989;257:F315\u2013F327.","DOI":"10.1152\/ajprenal.1989.257.3.F315"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Dubocovich ML, Langer SZ. Dopamine and alpha adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors. J Pharmacol Exp Ther. 1980;212:144\u2013152.","DOI":"10.1016\/S0022-3565(25)31928-2"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Blair ML, Reid IA, Ganong WF. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs. J Pharmacol Exp Ther. 1977;202:209\u2013215.","DOI":"10.1016\/S0022-3565(25)30947-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Krnjevic K, Phillis JW. Actions of certain amines on cerebral cortical neurones. Brit J Pharmacol. 1963;20:471\u2013490.","DOI":"10.1111\/j.1476-5381.1963.tb01484.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Biscoe TJ, Evans RH, Headley PM, Martin MR, Watkins JC. Structure-activity relations of excitatory amino acids on frog and rat spinal neurones. Br J Pharmacol. 1976;58:373\u2013382.","DOI":"10.1111\/j.1476-5381.1976.tb07714.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Miyamae T, Goshima Y, Shimizu M, Shibata T, Kawashima K, Ohshima E, et al. Some interactions of L-DOPA and its related compounds with glutamate receptors. Life Sci. 1999;64:1045\u20131054.","DOI":"10.1016\/S0024-3205(99)00031-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Talman WT, Perrone MH, Reis DJ. Evidence for L-glutamate as the neurotransmitter of baroreceptor afferent nerve fibers. Science. 1980;209:813\u2013815.","DOI":"10.1126\/science.6105709"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Gordon FJ, Leone C. Non-NMDA receptors in the nucleus of the tractus solitarius play the predominant role in mediating aortic baroreceptor reflexes. Brain Res. 1991;568:319\u2013322.","DOI":"10.1016\/0006-8993(91)91418-Z"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Yue JL, Goshima Y, Miyamae T, Misu Y. Evidence for L-dopa relevant to modulation of sympathetic activity in the rostral ventrolateral medulla of rats. Brain Res. 1993;629:310\u2013314.","DOI":"10.1016\/0006-8993(93)91336-Q"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Yue JL, Goshima Y, Misu Y. Transmitter-like L-3,4-dihydroxyphenylalanine tonically functions to mediate vasodepressor control in the caudal ventrolateral medulla of rats. Neurosci Lett. 1993;159:103\u2013106.","DOI":"10.1016\/0304-3940(93)90809-Y"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Urbanski RW, Sapru HN. Evidence for a sympathoexcitatory pathway from the nucleus tractus solitarii to the ventrolateral medullary pressor area. J Auton Nerv Syst. 1988;23:161\u2013174.","DOI":"10.1016\/0165-1838(88)90080-X"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Misu Y, Goshima Y, Miyamae T. Is DOPA a neurotransmitter? Trends Pharmacol Sci. 2002;23:262\u2013268.","DOI":"10.1016\/S0165-6147(02)02013-8"},{"key":"39","unstructured":"39 Masukawa D, Nakamura F, Koga M, Kamiya M, Chen S, Yamashita N, et al. Localization of ocular albinism-1 gene product GPR143 in the rat central nervous system. Neurosci Res. In press."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Goshima Y, Nakamura S, Misu Y. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices. J Pharmacol Exp Ther. 1991;258:466\u2013471.","DOI":"10.1016\/S0022-3565(25)20354-8"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4:1829.","DOI":"10.1038\/ncomms2852"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Goshima Y, Misu Y, Arai N, Misugi K. Nanomolar L-dopa facilitates release of dopamine via presynaptic beta-adrenoceptors: comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mice, an animal model for Parkinson\u2019s disease. Jpn J Pharmacol. 1991;55:93\u2013100.","DOI":"10.1254\/jjp.55.93"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature. 1998;396:683\u2013687.","DOI":"10.1038\/25360"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, et al. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature. 1998;396:679\u2013682.","DOI":"10.1038\/25354"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/126\/1\/126_14R03CR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T13:13:34Z","timestamp":1746364414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/126\/1\/126_14R03CR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.14r03cr","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}